Inclining preference for lab automation and the constant prevalence of infectious diseases worldwide are likely to add impetus to automated immunoassay analyzers demand over the next few years. The growth can be further owed to the awareness of the early diagnosis of the diseases to minimize the risks of severe body damage and complications when performing the diagnostic tests.

Estimates reveal that the global automated immunoassay analyzers market value will cross USD 25 billion in remuneration by 2024. Increasing demand for genetic testing and drug profiling along with an expanding elderly population base opting for improved health care services are some of the trends influencing the application growth.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/1727  

Consistent use of automated instruments across hospitals and laboratories will stimulate the adoption of automated immunoassay analyzers to cater to the growing need for quality diagnostic testing methods in case of staff shortage. The analyzers also enhance the efficiency as well as the quality of operations.

Industry share from chemiluminescence immunoassay analyzers is anticipated reach a CAGR of 16.4% up to 2024, considering their use to upgrade the work competence to carry out identification of hundreds of analytes per hour. They offer accuracy and sensitivity involved in the diagnosis that use low analyte concentration and exhibit attributes like high receptiveness and veracity.

Revenue for automated immunoassay analyzers from endocrinology application was valued at more than USD 1,641.3 million in 2017 and is expected to witness considerable expansion. This can be attributed to an expanding adolescent population that is prone to the development of the endocrine gland caused by hormonal imbalance and the prevailing condition of diabetes.

Request for customization @ https://www.decresearch.com/roc/1727

Extensive application of automated immunoassay analyzers in the pharmaceutical and biotechnology sector is slated to show a CAGR of 14.4% in the coming years. This includes drug monitoring treatments that comprise of diagnosis of health complications like toxicity, identification as well as the gradual customization of the optimal drug pertaining to the concerned patient.

U.K. held the largest market share owing to a consistent prevalence of infectious diseases. Automated immunoassay analyzers market was valued at USD 767.8 million in revenue share in 2017 across the country. Infection ailments posed a challenge for the economic as well as the health sector in the U.K. and their treatment costs contributed to more than EUR 30 billion in the same year.

India automated immunoassay analyzer market is pegged to rise at 18.2% CAGR through 2024 with the surge in the number of laboratories that perform routine tests. There is also an increasing awareness among the regional population about general health awareness.

Automated immunoassay analyzer manufacturers are mainly focused on introducing technologically advanced and innovative products to expand their global reach. They are also keen on extending their offerings to cater to the requirements of test volumes, assay menu, budget, and automation level among various laboratory settings to gain a competitive edge.

For instance, Roche Diagnostics, in September 2020 launched Elecsys, an anti-SARS-CoV-2 S antibody test that is awarded the CE Mark. The immunoassay analyzer is used to inspect and measure antibodies in individuals infected with the novel coronavirus besides showing potential in depicting a vaccine-induced immune response. Abbott Diagnostics, Biokit, Siemens Healthcare, Biomerieux, and Luminex Corporation, are some of the other global firms.

Partial Chapter of the Table of Content

Chapter 2.     Executive Summary

2.1. Automated immunoassay analyzers industry 360⁰ synopsis, 2013 - 2024

2.1.1.  Business trends

2.1.2.  Product trends

2.1.3.  Application trends

2.1.4.  End-use trends

2.1.5.  Regional trends   

Chapter 3.     Automated Immunoassay Analyzers Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 – 2024

3.3. Industry impact forces

3.3.1.  Growth drivers

3.3.1.1.  Incessant introduction of advanced products

3.3.1.2.  Rising trend towards lab automation

3.3.1.3.  Increasing prevalence of infectious diseases

3.3.1.4.  Expanding clinical applications of immunoassay analyzers

3.3.2.  Industry pitfalls & challenges

3.3.2.1.  Dearth of qualified and trained professionals

3.4. Growth potential analysis

3.4.1.  By product

3.4.2.  By application

3.4.3.  By end-user

3.5. Regulatory landscape

3.5.1.  U.S.

3.5.2.  Europe

3.6. Porter’s analysis

3.7. Competitive landscape, 2017

3.7.1.   Business overview

3.7.2.   Revenue analysis

3.7.3.   Product landscape

3.7.4.   Strategy dashboard

3.8. PESTEL analysis

Browse complete Table of Contents (ToC) of this research report @ https://www.decresearch.com/toc/detail/automated-immunoassay-analyzers-market